BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1310779)

  • 1. A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance.
    Hwang CB; Ruffner KL; Coen DM
    J Virol; 1992 Mar; 66(3):1774-6. PubMed ID: 1310779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro mutagenesis of the herpes simplex virus type 1 DNA polymerase gene results in altered drug sensitivity of the enzyme.
    Matthews JT; Carroll RD; Stevens JT; Haffey ML
    J Virol; 1989 Nov; 63(11):4913-8. PubMed ID: 2552170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.
    Coen DM; Fleming HE; Leslie LK; Retondo MJ
    J Virol; 1985 Feb; 53(2):477-88. PubMed ID: 2982032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aphidicolin resistance in herpes simplex virus type I reveals features of the DNA polymerase dNTP binding site.
    Hall JD; Wang YS; Pierpont J; Berlin MS; Rundlett SE; Woodward S
    Nucleic Acids Res; 1989 Nov; 17(22):9231-44. PubMed ID: 2555788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities.
    Larder BA; Darby G
    Virology; 1985 Oct; 146(2):262-71. PubMed ID: 2996220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
    Schmit I; Boivin G
    J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of a herpes simplex virus clinical isolate exhibiting resistance to acyclovir and foscarnet.
    Pelosi E; Hicks KA; Sacks SL; Coen DM
    Adv Exp Med Biol; 1992; 312():151-8. PubMed ID: 1325102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical mapping of drug resistance mutations defines an active center of the herpes simplex virus DNA polymerase enzyme.
    Knopf KW; Kaufman ER; Crumpacker C
    J Virol; 1981 Sep; 39(3):746-57. PubMed ID: 6270349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activities.
    Furman PA; Coen DM; St Clair MH; Schaffer PA
    J Virol; 1981 Dec; 40(3):936-41. PubMed ID: 6275127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-base change within the DNA polymerase locus of herpes simplex virus type 2 can confer resistance to aphidicolin.
    Tsurumi T; Maeno K; Nishiyama Y
    J Virol; 1987 Feb; 61(2):388-94. PubMed ID: 3027369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The herpes simplex virus type 1 DNA polymerase gene: site of phosphonoacetic acid resistance mutation in strain Angelotti is highly conserved.
    Knopf CW
    J Gen Virol; 1987 May; 68 ( Pt 5)():1429-33. PubMed ID: 3033142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic mechanisms of resistance to acyclovir in herpes simplex virus.
    Crumpacker CS; Schnipper LE; Chartrand P; Knopf KW
    Am J Med; 1982 Jul; 73(1A):361-8. PubMed ID: 6285723
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical and genetic analysis of acyclovir-resistant mutants of herpes simplex virus type 1.
    Coen DM; Schaffer PA; Furman PA; Keller PM; St Clair MH
    Am J Med; 1982 Jul; 73(1A):351-60. PubMed ID: 6285722
    [No Abstract]   [Full Text] [Related]  

  • 14. Fine mapping and molecular cloning of mutations in the herpes simplex virus DNA polymerase locus.
    Coen DM; Aschman DP; Gelep PT; Retondo MJ; Weller SK; Schaffer PA
    J Virol; 1984 Jan; 49(1):236-47. PubMed ID: 6317891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir.
    Collins P; Larder BA; Oliver NM; Kemp S; Smith IW; Darby G
    J Gen Virol; 1989 Feb; 70 ( Pt 2)():375-82. PubMed ID: 2543743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversion of mutations in the thymidine kinase gene in herpes simplex viruses resistant to phosphonoacetate.
    Campione-Piccardo J; Rawls WE
    Can J Microbiol; 1984 May; 30(5):560-4. PubMed ID: 6331620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the herpes simplex virus DNA polymerase gene can confer resistance to 9-beta-D-arabinofuranosyladenine.
    Coen DM; Furman PA; Gelep PT; Schaffer PA
    J Virol; 1982 Mar; 41(3):909-18. PubMed ID: 6284981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the DNA polymerases induced by a group of herpes simplex virus type I variants selected for growth in the presence of phosphonoformic acid.
    Derse D; Bastow KF; Cheng Y
    J Biol Chem; 1982 Sep; 257(17):10251-60. PubMed ID: 6286645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of penciclovir against clinical isolates of acyclovir-resistant and foscarnet-resistant herpes simplex virus.
    Safrin S; Phan L
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2241-3. PubMed ID: 8257152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of herpes simplex virus to adenine arabinoside and E-5-(2-bromovinyl)-2'-deoxyuridine: a physical analysis.
    Crumpacker CS; Schnipper LE; Kowalsky PN; Sherman DM
    J Infect Dis; 1982 Aug; 146(2):167-72. PubMed ID: 6286786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.